| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
From the Experimental Chemotherapy Laboratory,*
the
Pathology Department,
and the Surgical
Department,
Regina Elena Cancer Institute,
Rome, Italy; the Peter MacCallum Cancer
Institute,§
Melbourne, Australia; the
Department of Microbiology and Immunology,¶
Kimmel
Cancer Institute, Thomas Jefferson University, Philadelphia,
Pennsylvania; and the Department of Biomedical Science,||
University of Modena, Modena, Italy
The aim of this study was twofold: to assess the relationship between c-Myb and Bcl-x expression and to evaluate the prognostic significance of their expression in colorectal carcinoma (CRC) patients. Analysis of tumors from 91 CRC patients for expression of c-Myb and Bcl-x revealed a significant relationship between these two proteins. Kaplan-Meier’s analysis showed an increased risk of relapse and death in patients whose tumor specimens displayed high c-Myb levels and Bcl-x positivity. Similar results were also observed excluding Dukes’ D patients. Molecular analysis using three c-Myb-overexpressing LoVo clones indicated that c-Myb overexpression was accompanied by up-regulation of Bcl-xL protein and mRNA. Tumors originating from these clones injected in nude mice were significantly larger than those formed in mice injected with parental or vector-transfected LoVo cells. Moreover, tumors derived from parental and control vector-transfected but not from c-Myb-overexpressing LoVo cells showed high frequency of apoptotic cells. These results provide direct evidence of an association between c-Myb and Bcl-x expression and suggest that expression of both molecules might be a useful prognostic marker in CRC.
This article has been cited by other articles:
 |
|
 |
|
  Y.-C. Lin, M.-W. Kuo, J. Yu, H.-H. Kuo, R.-J. Lin, W.-L. Lo, and A. L. Yu c-Myb Is an Evolutionary Conserved miR-150 Target and miR-150/c-Myb Interaction Is Important for Embryonic Development Mol. Biol. Evol., October 1, 2008; 25(10): 2189 - 2198. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Drabsch, H. Hugo, R. Zhang, D. H. Dowhan, Y. R. Miao, A. M. Gewirtz, S. C. Barry, R. G. Ramsay, and T. J. Gonda Mechanism of and requirement for estrogen-regulated MYB expression in estrogen-receptor-positive breast cancer cells PNAS, August 21, 2007; 104(34): 13762 - 13767. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Kroemer, L. Galluzzi, and C. Brenner Mitochondrial Membrane Permeabilization in Cell Death Physiol Rev, January 1, 2007; 87(1): 99 - 163. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Corradini, V. Cesi, V. Bartella, E. Pani, R. Bussolari, O. Candini, and B. Calabretta Enhanced Proliferative Potential of Hematopoietic Cells Expressing Degradation-resistant c-Myb Mutants J. Biol. Chem., August 26, 2005; 280(34): 30254 - 30262. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. G. Ramsay, S. Micallef, S. Lightowler, M. L. Mucenski, T. Mantamadiotis, and I. Bertoncello c-myb Heterozygous Mice Are Hypersensitive to 5-Fluorouracil and Ionizing Radiation Mol. Cancer Res., June 1, 2004; 2(6): 354 - 361. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Tanno, A. Negroni, R. Vitali, M. C. Pirozzoli, V. Cesi, C. Mancini, B. Calabretta, and G. Raschella Expression of Insulin-like Growth Factor-binding Protein 5 in Neuroblastoma Cells Is Regulated at the Transcriptional Level by c-Myb and B-Myb via Direct and Indirect Mechanisms J. Biol. Chem., June 21, 2002; 277(26): 23172 - 23180. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
